Advertisement

Topics

US court dismisses Teva's Rimsa deal fraud claims

05:47 EDT 3 Aug 2017 | Globes

New York Supreme Court Judge Peter Sherwood did not fully reject Teva's claims of breach of contract on the $2.3 billion Mexican acquisition.

Original Article: US court dismisses Teva's Rimsa deal fraud claims

NEXT ARTICLE

More From BioPortfolio on "US court dismisses Teva's Rimsa deal fraud claims"

Quick Search
Advertisement
 

Relevant Topics

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...

Mergers & Acquisitions
Commercial and market reports on mergers and acquisitions in the biotechnology, pharmaceutical, medical device and life-science industries. Mergers and acquisitions (abbreviated M&A;) is an aspect of corporate strategy, corporate finance and manageme...